<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Drive_%2B_Fly</id>
	<title>Drive + Fly - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Drive_%2B_Fly"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Drive_%2B_Fly&amp;action=history"/>
	<updated>2026-05-13T03:27:17Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Drive_%2B_Fly&amp;diff=7846&amp;oldid=prev</id>
		<title>Aidan at 12:50, 14 May 2021</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Drive_%2B_Fly&amp;diff=7846&amp;oldid=prev"/>
		<updated>2021-05-14T12:50:55Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;a href=&quot;https://idwiki.org/index.php?title=Drive_%2B_Fly&amp;amp;diff=7846&amp;amp;oldid=4187&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Drive_%2B_Fly&amp;diff=4187&amp;oldid=prev</id>
		<title>Maintenance script: Imported from text file</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Drive_%2B_Fly&amp;diff=4187&amp;oldid=prev"/>
		<updated>2020-07-04T01:17:32Z</updated>

		<summary type="html">&lt;p&gt;Imported from text file&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Driving ==&lt;br /&gt;
&lt;br /&gt;
=== Coronary Artery Disease (CAD) ===&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Syndrome&lt;br /&gt;
! Private&lt;br /&gt;
! Commercial&lt;br /&gt;
|-&lt;br /&gt;
| STEMI&lt;br /&gt;
| 1 mo from D/C&lt;br /&gt;
| 3 mo from D/C&lt;br /&gt;
|-&lt;br /&gt;
| NSTEMI with sig LV damage&lt;br /&gt;
| 1 mo from D/C&lt;br /&gt;
| 3 mo from D/C&lt;br /&gt;
|-&lt;br /&gt;
| NSTEMI with PCI&lt;br /&gt;
| 48 h after PCI&lt;br /&gt;
| 7 days after PCI&lt;br /&gt;
|-&lt;br /&gt;
| NSTEMI without PCI&lt;br /&gt;
| 7 days after D/C&lt;br /&gt;
| 30 days after D/C&lt;br /&gt;
|-&lt;br /&gt;
| Unstable angina with PCI&lt;br /&gt;
| 48 h after PCI&lt;br /&gt;
| 7 days after PCI&lt;br /&gt;
|-&lt;br /&gt;
| Unstable angina without PCI&lt;br /&gt;
| 7 days after D/C&lt;br /&gt;
| 30 days after D/C&lt;br /&gt;
|-&lt;br /&gt;
| Stable angina or asymptomatic CAD&lt;br /&gt;
| No restriction&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| Stable CAD with PCI&lt;br /&gt;
| 48 h after PCI&lt;br /&gt;
| 7 days after PCI&lt;br /&gt;
|-&lt;br /&gt;
| CABG&lt;br /&gt;
| 1 mo after D/C&lt;br /&gt;
| 3 mo after D/C&lt;br /&gt;
|-&lt;br /&gt;
| Any, with 50% left main&lt;br /&gt;
|&lt;br /&gt;
| Disqualified until treated&lt;br /&gt;
|-&lt;br /&gt;
| Any, with 70% left main&lt;br /&gt;
| Disqualified until treated&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Minor/non-significant LV damage is the abscence of new wall motion abnormality&lt;br /&gt;
&lt;br /&gt;
=== Dysrhythmias ===&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Syndrome&lt;br /&gt;
! Private&lt;br /&gt;
! Commercial&lt;br /&gt;
|-&lt;br /&gt;
| VF without reversible cause&lt;br /&gt;
| 6 mo after event&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| Unstable VT&lt;br /&gt;
| 6 mo after event&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| VT or VF with reversible cause&lt;br /&gt;
| Until cause is treated&lt;br /&gt;
| Until cause is treated&lt;br /&gt;
|-&lt;br /&gt;
| Sustained VT, LVEF &amp;amp;lt;30%&lt;br /&gt;
| 3 mo after event &amp;amp;amp; controlled&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| Sustained VT, LVEF ≥30%&lt;br /&gt;
| 4 wk after event &amp;amp;amp; controlled&lt;br /&gt;
| 3 mo after event&lt;br /&gt;
|-&lt;br /&gt;
| NSVT&lt;br /&gt;
| No restriction&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| Paroxysmal SVT/AF with impaired LOC&lt;br /&gt;
| When controlled&lt;br /&gt;
| When controlled&lt;br /&gt;
|-&lt;br /&gt;
| SVT/AF without impaired LOC&lt;br /&gt;
| No restriction&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| Symptomatic SSS&lt;br /&gt;
| Until treated&lt;br /&gt;
| Until treated&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
AF = atrial fibrillation or flutter&lt;br /&gt;
&lt;br /&gt;
==== Heart Block ====&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Syndrome&lt;br /&gt;
! Private&lt;br /&gt;
! Commercial&lt;br /&gt;
|-&lt;br /&gt;
| Isolated 1º HB&lt;br /&gt;
| No restriction&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| Isolated RBBB&lt;br /&gt;
| No restriction&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| Isolated LAFB&lt;br /&gt;
| No restriction&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| Isolated LPFB&lt;br /&gt;
| No restriction&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| LBBB&lt;br /&gt;
| If no impaired LOC&lt;br /&gt;
| If no impaired LOC*&lt;br /&gt;
|-&lt;br /&gt;
| Bifascicular block&lt;br /&gt;
| If no impaired LOC&lt;br /&gt;
| If no impaired LOC*&lt;br /&gt;
|-&lt;br /&gt;
| 2º HB, Mobitz I&lt;br /&gt;
| If no impaired LOC&lt;br /&gt;
| If no impaired LOC*&lt;br /&gt;
|-&lt;br /&gt;
| 1º HB with bifascicular block&lt;br /&gt;
| If no impaired LOC&lt;br /&gt;
| If no impaired LOC*&lt;br /&gt;
|-&lt;br /&gt;
| 2º HB, Mobitz II&lt;br /&gt;
| Disqualified&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| Alternating LBBB &amp;amp;amp; RBBB&lt;br /&gt;
| Disqualified&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| Acquired 3º HB&lt;br /&gt;
| Disqualified&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| Congenital 3º HB&lt;br /&gt;
| If no impaired LOC&lt;br /&gt;
| If no impaired LOC**&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
* and no higher block on annual 24 h Holter ** and QRS ≤110, and no pauses ≥3 sec on annual 24 H holter&lt;br /&gt;
&lt;br /&gt;
==== Pacemakers and ICDs ====&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Syndrome&lt;br /&gt;
! Private&lt;br /&gt;
! Commercial&lt;br /&gt;
|-&lt;br /&gt;
| PPM&lt;br /&gt;
| 1 wk after implant*&lt;br /&gt;
| 1 mo after implant*&lt;br /&gt;
|-&lt;br /&gt;
| ICD for 1º prophylaxis&lt;br /&gt;
| 4 wk after implant&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| ICD for symptomatic VF/VT&lt;br /&gt;
| 6 mo after event&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| ICD for sustained VT&lt;br /&gt;
| 1 wk after implant&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| ICD giving shocks&lt;br /&gt;
| 6 mo after event&lt;br /&gt;
| Disqualified&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
* as well as no impaired LOC, normal sensing and capture, and no evidence of PPM malfunction&lt;br /&gt;
&lt;br /&gt;
==== Other Dysrhythmias ====&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Syndrome&lt;br /&gt;
! Private&lt;br /&gt;
! Commercial&lt;br /&gt;
|-&lt;br /&gt;
| Brugada, long QT, or arrhythmogenic RV cardiomyopathy&lt;br /&gt;
| Once investigated&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| Cather ablation&lt;br /&gt;
| 48 h after D/C&lt;br /&gt;
| 1 wk after D/C&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Syncope ===&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Syndrome&lt;br /&gt;
! Private&lt;br /&gt;
! Commercial&lt;br /&gt;
|-&lt;br /&gt;
| 1x vasovagal&lt;br /&gt;
| No restriction&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| Treated cause (e.g. with PPM)&lt;br /&gt;
| 1 wk after treatment&lt;br /&gt;
| 1 mo after treatment&lt;br /&gt;
|-&lt;br /&gt;
| Reversible cause (e.g. dehydration)&lt;br /&gt;
| After treatment&lt;br /&gt;
| After treatment&lt;br /&gt;
|-&lt;br /&gt;
| Situational syncope with avoidable trigger&lt;br /&gt;
| 1 wk after episode&lt;br /&gt;
| 1 wk after episode&lt;br /&gt;
|-&lt;br /&gt;
| 1x unexplained&lt;br /&gt;
| 1 wk after episode&lt;br /&gt;
| 12 mo after episode&lt;br /&gt;
|-&lt;br /&gt;
| Recurrent vasovagal in 12 mo&lt;br /&gt;
| 1 wk after episode&lt;br /&gt;
| 12 mo after episode&lt;br /&gt;
|-&lt;br /&gt;
| Recurrent unexplained in 12 mo&lt;br /&gt;
| 3 mo after episode&lt;br /&gt;
| 12 mo after episode&lt;br /&gt;
|-&lt;br /&gt;
| Due to arrhythmia&lt;br /&gt;
| See Dysrhythmia section&lt;br /&gt;
| See Dysrhythmia section&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Valvular Disease ===&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Syndrome&lt;br /&gt;
! Private&lt;br /&gt;
! Commerical&lt;br /&gt;
|-&lt;br /&gt;
| AS&lt;br /&gt;
| NYHA I or II with no impaired LOC&lt;br /&gt;
| Asymptomatic, NYHA I, AVA ≥1cm, EF ≥35%&lt;br /&gt;
|-&lt;br /&gt;
| AR/MS/MR&lt;br /&gt;
| NYHA I or II with no impaired LOC&lt;br /&gt;
| No impaired LOC, NYHA I, EF ≥35%&lt;br /&gt;
|-&lt;br /&gt;
| Mechanical valve&amp;lt;br/&amp;gt;BioMVR or MV repair with AF&lt;br /&gt;
| 6 wk from D/C&amp;lt;br/&amp;gt;No embolic, on A/C&lt;br /&gt;
| 3 mo from D/C&amp;lt;br/&amp;gt;No embolic, on A/C, NYHA I, EF ≥35%&lt;br /&gt;
|-&lt;br /&gt;
| BioAVR&amp;lt;br/&amp;gt;BioMVR or MV repair without AF&lt;br /&gt;
| 6 wk after D/C&amp;lt;br/&amp;gt;No embolic&lt;br /&gt;
| 3 mo after D/C&amp;lt;br/&amp;gt;No embolic, NYHA I, EF ≥35%&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Heart Failure ===&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Syndrome&lt;br /&gt;
! Private&lt;br /&gt;
! Commercial&lt;br /&gt;
|-&lt;br /&gt;
| NYHA I&lt;br /&gt;
| No restriction&lt;br /&gt;
| EF ≥35%&lt;br /&gt;
|-&lt;br /&gt;
| NYHA II&lt;br /&gt;
| No restriction&lt;br /&gt;
| EF ≥35%&lt;br /&gt;
|-&lt;br /&gt;
| NYHA III&lt;br /&gt;
| No restriction&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| NYHA IV&lt;br /&gt;
| Disqualified&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| Receiving inotropes&lt;br /&gt;
| Disqualified&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| LVAD&lt;br /&gt;
| Disqualified&lt;br /&gt;
| Disqualified&lt;br /&gt;
|-&lt;br /&gt;
| Heart transplant&lt;br /&gt;
| 6 wk after D/C&amp;lt;br/&amp;gt;NYHA I or II, on stable Rx&lt;br /&gt;
| 6 mo after D/C&amp;lt;br/&amp;gt;EF ≥35%, NYHA I&amp;lt;br/&amp;gt;No evidence of ischemia on testing&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Hypertrophic Cardiomyopathy ===&lt;br /&gt;
&lt;br /&gt;
* Private: no impaired LOC&lt;br /&gt;
* Commercial: LV wall thickness &amp;amp;lt;30 mm, no syncope, no NSVT on annual 24 h Holter, no FHx sudden death at young age, and no hypotension with exercise&lt;br /&gt;
&lt;br /&gt;
== Flying ==&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Condition&lt;br /&gt;
! NYHA&lt;br /&gt;
! Travel&lt;br /&gt;
|-&lt;br /&gt;
| Angina&lt;br /&gt;
| I/II&lt;br /&gt;
| No restriction&lt;br /&gt;
|-&lt;br /&gt;
| Angina&lt;br /&gt;
| III&lt;br /&gt;
| Supplemental oxygen required&lt;br /&gt;
|-&lt;br /&gt;
| Angina&lt;br /&gt;
| IV&lt;br /&gt;
| Only if medically necessary and accompanied&lt;br /&gt;
|-&lt;br /&gt;
| Recent MI&lt;br /&gt;
| I&lt;br /&gt;
| 1 to 2 weeks for repatriation if uncomplicated and revascularized&amp;lt;br/&amp;gt;6 to 8 weeks for elective travel&lt;br /&gt;
|-&lt;br /&gt;
| Heart failure&lt;br /&gt;
| I/II&lt;br /&gt;
| Unrestricted&lt;br /&gt;
|-&lt;br /&gt;
| Heart failure&lt;br /&gt;
| III&lt;br /&gt;
| Supplemental oxygen required&lt;br /&gt;
|-&lt;br /&gt;
| Valvular disease&lt;br /&gt;
| I/II&lt;br /&gt;
| Unrestricted; supplemental oxygen if pulmonary hypertension&lt;br /&gt;
|-&lt;br /&gt;
| Valvular disease&lt;br /&gt;
| III&lt;br /&gt;
| Supplemental oxygen required&lt;br /&gt;
|-&lt;br /&gt;
| Valvular disease&lt;br /&gt;
| IV&lt;br /&gt;
| Only if medically necessary and accompanied&lt;br /&gt;
|-&lt;br /&gt;
| Congenital&lt;br /&gt;
| I/II&lt;br /&gt;
| Unrestricted; supplemental oxygen if PaO2 &amp;amp;lt;70 mmHg&lt;br /&gt;
|-&lt;br /&gt;
| Congenital&lt;br /&gt;
| III&lt;br /&gt;
| Supplemental oxygen required&lt;br /&gt;
|-&lt;br /&gt;
| Congenital&lt;br /&gt;
| IV&lt;br /&gt;
| Only if medically necessary and accompanied&lt;br /&gt;
|-&lt;br /&gt;
| Recent CABG/valve surgery&lt;br /&gt;
| I/II&lt;br /&gt;
| 4 days post-surgery if Hb ≥90 and flight &amp;amp;lt;2 h&amp;lt;br/&amp;gt;7 days post-surgery if Hb ≥90 and flight ≤2 h&lt;br /&gt;
|-&lt;br /&gt;
| PCI/ASD closure&lt;br /&gt;
| I/II&lt;br /&gt;
| 1 day postprocedure&amp;lt;br/&amp;gt;If PCI, following CAD guidelines, above&lt;br /&gt;
|-&lt;br /&gt;
| Post-arrhythmia procedure&lt;br /&gt;
| I/II&lt;br /&gt;
| Well-controlled SVT: unrestricted&amp;lt;br/&amp;gt;1 day post-procedure for SVT&amp;lt;br/&amp;gt;2 days post-procedure for ventricular arrhythmias&lt;br /&gt;
|-&lt;br /&gt;
| Post-arrhythmia procedure&lt;br /&gt;
| III/IV&lt;br /&gt;
| Uncontrolled hemodynamically significant ventricular arrhythmias should not fly&lt;br /&gt;
|-&lt;br /&gt;
| Post-PPM/ICD/loop recorder&lt;br /&gt;
| I/II&lt;br /&gt;
| 1 day post-implant if no pneumothorax, and device is functioning&lt;br /&gt;
|-&lt;br /&gt;
| ICD patients&lt;br /&gt;
| I/II&lt;br /&gt;
| 1 mo following last shock associated with severe presyncope or syncope&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== DVT Prophylaxis ===&lt;br /&gt;
&lt;br /&gt;
Routine precautions include:&lt;br /&gt;
&lt;br /&gt;
* Avoid stasis, move around cabin, isometric calf exercises&lt;br /&gt;
* Avoid dehydration, alcohol, and caffeine&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
! Patient Population&lt;br /&gt;
! Recommendations&lt;br /&gt;
|-&lt;br /&gt;
| Flight &amp;amp;lt;12 h&lt;br /&gt;
| Routine&lt;br /&gt;
|-&lt;br /&gt;
| Flight ≥12 h, low risk&lt;br /&gt;
| Routine&lt;br /&gt;
|-&lt;br /&gt;
| Flight ≥12 h, moderate risk&lt;br /&gt;
| Routine with pressure stockings or ASA 160-325 mg 4 h before flight&lt;br /&gt;
|-&lt;br /&gt;
| Flight ≥12 h, high risk&lt;br /&gt;
| Routine with pressure stockings or LMWH 2 h before flight&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Moderate risk:&amp;#039;&amp;#039;&amp;#039; patients aged &amp;amp;gt;75 years, women &amp;amp;gt;45 on estrogen, pregnant or post-partum women, age &amp;amp;lt;45 years with heterozygous FVL or prothrombin mutations, patients with varicose veins, heart failure, MI within 6 weeks, or lower limb trauma within 6 weeks&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;High risk:&amp;#039;&amp;#039;&amp;#039; previous VTE, major surgery within 6 weeks, active malignancy, gross obesity or marked immobility due to neuromuscular or cardiorespiratory disease, people age &amp;amp;gt;45 with antithrombin/protein C/protein S deficiency, people age &amp;amp;gt;75 with cardiac or pulmonary disease&lt;br /&gt;
&lt;br /&gt;
== Further Reading ==&lt;br /&gt;
&lt;br /&gt;
* [https://ccs.ca/images/Guidelines/Guidelines_POS_Library/DF_CC_2003_ES.pdf CCS Consensus Conference 2003: Assessment of the cardiac patient for fitness to drive and fly – Executive summary]&lt;br /&gt;
&lt;br /&gt;
[[Category:Guidelines]]&lt;br /&gt;
[[Category:Cardiology]]&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>